Systemic therapy in the management of metastatic or advanced salivary gland cancers

A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

(2011) Athanassios Argiris et al.   CANCER

Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review

(2010) Scott A Laurie et al.   LANCET ONCOLOGY

A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer

(2009) Scott A. Laurie et al.   CANCER

NF-κB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motilityin vitro

(2009) Jiali Zhang et al.   CELL PROLIFERATION

Major and minor salivary gland tumors

(2009) Marco Guzzo et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)

(2008) C.M.L. van Herpen et al.   EUROPEAN JOURNAL OF CANCER

Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases

(2008) Adam D. Elkin et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Biological therapy of salivary duct carcinoma

(2008) M Nashed et al.   JOURNAL OF LARYNGOLOGY AND OTOLOGY

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

(2008) L.D. Locati et al.   ORAL ONCOLOGY

Successful treatment of pulmonary metastatic salivary ductal carcinoma with trastuzumab-based therapy

(2007) Aleix Prat et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK